These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 19012471)
1. Prevalence, risk factors, and clinical features of thyroid-associated ophthalmopathy in multiethnic Malaysian patients with Graves' disease. Lim SL; Lim AK; Mumtaz M; Hussein E; Wan Bebakar WM; Khir AS Thyroid; 2008 Dec; 18(12):1297-301. PubMed ID: 19012471 [TBL] [Abstract][Full Text] [Related]
2. Prevalence of Graves' ophthalmopathy in patients with Graves' disease presenting to a referral centre in north India. Reddy SV; Jain A; Yadav SB; Sharma K; Bhatia E Indian J Med Res; 2014 Jan; 139(1):99-104. PubMed ID: 24604044 [TBL] [Abstract][Full Text] [Related]
3. Acquired lower eyelid epiblepharon in thyroid-associated ophthalmopathy of Koreans. Park SW; Khwarg SI; Kim N; Lee MJ; Choung HK Ophthalmology; 2012 Feb; 119(2):390-5. PubMed ID: 21978591 [TBL] [Abstract][Full Text] [Related]
4. Risk factors for developing thyroid-associated ophthalmopathy among individuals with Graves disease. Stein JD; Childers D; Gupta S; Talwar N; Nan B; Lee BJ; Smith TJ; Douglas R JAMA Ophthalmol; 2015 Mar; 133(3):290-6. PubMed ID: 25502604 [TBL] [Abstract][Full Text] [Related]
5. Age and gender influence on clinical manifestations of thyroid-associated ophthalmopathy: a case series of 2479 Chinese patients. Yang M; He W Front Endocrinol (Lausanne); 2024; 15():1434155. PubMed ID: 39421533 [TBL] [Abstract][Full Text] [Related]
6. Epidemiology and Clinical Features of Thyroid-associated Orbitopathy in Accra. Ackuaku-Dogbe EM; Akpalu J; Abaidoo B Middle East Afr J Ophthalmol; 2017; 24(4):183-189. PubMed ID: 29422752 [TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics of moderate-to-severe thyroid associated ophthalmopathy in 354 Chinese cases. Li Q; Ye H; Ding Y; Chen G; Liu Z; Xu J; Chen R; Yang H PLoS One; 2017; 12(5):e0176064. PubMed ID: 28472149 [TBL] [Abstract][Full Text] [Related]
8. Thyroid eye disease: a Southeast Asian experience. Lim NC; Sundar G; Amrith S; Lee KO Br J Ophthalmol; 2015 Apr; 99(4):512-8. PubMed ID: 25361748 [TBL] [Abstract][Full Text] [Related]
9. Thyroid autoantibody profiles in ophthalmic dominant and thyroid dominant Graves' disease differ and suggest ophthalmopathy is a multiantigenic disease. Goh SY; Ho SC; Seah LL; Fong KS; Khoo DH Clin Endocrinol (Oxf); 2004 May; 60(5):600-7. PubMed ID: 15104563 [TBL] [Abstract][Full Text] [Related]
10. Graves' ophthalmopathy in relation to cigarette smoking and ethnic origin. Tellez M; Cooper J; Edmonds C Clin Endocrinol (Oxf); 1992 Mar; 36(3):291-4. PubMed ID: 1563082 [TBL] [Abstract][Full Text] [Related]
11. [The level of cotinine - marker of tobacco smoking, in patients with hyperthyroidism]. Czarnywojtek A; Zgorzalewicz-Stachowiak M; Florek E; Piekoszewski W; Warmuz-Stangierska I; Kulińska-Niedziela I; Komar-Rychlicka K; Sowiński J Endokrynol Pol; 2006; 57(6):612-8. PubMed ID: 17253434 [TBL] [Abstract][Full Text] [Related]
12. [Progression of the pathogenesis of thyroid associated ophthalmopathy]. Wang L; Ma JM Zhonghua Yan Ke Za Zhi; 2017 Jun; 53(6):474-480. PubMed ID: 28606272 [TBL] [Abstract][Full Text] [Related]
13. Serum concentrations of proinflammatory cytokines in Graves' disease: effect of treatment, thyroid function, ophthalmopathy and cigarette smoking. Salvi M; Pedrazzoni M; Girasole G; Giuliani N; Minelli R; Wall JR; Roti E Eur J Endocrinol; 2000 Aug; 143(2):197-202. PubMed ID: 10913938 [TBL] [Abstract][Full Text] [Related]
14. Exophthalmos of patients with Graves' disease in Chinese of Taiwan. Tsai CC; Kau HC; Kao SC; Hsu WM Eye (Lond); 2006 May; 20(5):569-73. PubMed ID: 15905866 [TBL] [Abstract][Full Text] [Related]
15. Predictive Model for Graves' Ophthalmopathy in Patients with New-Onset Graves' Disease. Ahn HY; Lee J; Lee JK Thyroid; 2022 Dec; 32(12):1559-1567. PubMed ID: 36128837 [No Abstract] [Full Text] [Related]
16. Treatment of Graves' disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab: an open study. Salvi M; Vannucchi G; Campi I; Currò N; Dazzi D; Simonetta S; Bonara P; Rossi S; Sina C; Guastella C; Ratiglia R; Beck-Peccoz P Eur J Endocrinol; 2007 Jan; 156(1):33-40. PubMed ID: 17218723 [TBL] [Abstract][Full Text] [Related]
17. Antibody-dependent cell-mediated cytotoxicity against orbital target cells in thyroid-associated ophthalmopathy and related disorders; close relationship between serum cytotoxic antibodies and parameters of eye muscle dysfunction. Barsouk A; Peele KA; Kiljanski J; Stolarski C; Nebes V; Kennerdell JS; Volpe R; Wall JR J Endocrinol Invest; 1996 Jun; 19(6):334-41. PubMed ID: 8844451 [TBL] [Abstract][Full Text] [Related]
18. IL-17 and IL-38 gene polymorphisms in thyroid-associated ophthalmopathy. Mussakulova A; Balmukhanova A; Aubakirova A; Khamdiyeva O; Zhunussova G; Balmukhanova A Int Ophthalmol; 2024 Sep; 44(1):379. PubMed ID: 39292290 [TBL] [Abstract][Full Text] [Related]
19. Are ethnicity, social grade, and social deprivation associated with severity of thyroid-associated ophthalmopathy? Edmunds MR; Huntbach JA; Durrani OM Ophthalmic Plast Reconstr Surg; 2014; 30(3):241-5. PubMed ID: 24608325 [TBL] [Abstract][Full Text] [Related]
20. Thyroid-associated ophthalmopathy after treatment for Graves' hyperthyroidism with antithyroid drugs or iodine-131. Träisk F; Tallstedt L; Abraham-Nordling M; Andersson T; Berg G; Calissendorff J; Hallengren B; Hedner P; Lantz M; Nyström E; Ponjavic V; Taube A; Törring O; Wallin G; Asman P; Lundell G; J Clin Endocrinol Metab; 2009 Oct; 94(10):3700-7. PubMed ID: 19723755 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]